BCM

Burrage Capital Management Portfolio holdings

AUM $99.7M
1-Year Est. Return 65.92%
This Quarter Est. Return
1 Year Est. Return
+65.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.7M
AUM Growth
-$22.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
28
New
Increased
Reduced
Closed

Top Buys

1
+$4.82M
2
+$2.87M
3
+$2.26M
4
RVMD icon
Revolution Medicines
RVMD
+$1.59M
5
INZY
Inozyme Pharma
INZY
+$1.24M

Top Sells

1
+$9.48M
2
+$7.59M
3
+$5.47M
4
TVRD
Tvardi Therapeutics
TVRD
+$3.91M
5
FULC icon
Fulcrum Therapeutics
FULC
+$3.77M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
1
BioCryst Pharmaceuticals
BCRX
$1.49B
$13.7M 13.71%
864,916
NTLA icon
2
Intellia Therapeutics
NTLA
$1.41B
$10.3M 10.33%
63,634
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$6.95M 6.97%
836,802
+272,247
EPIX
4
DELISTED
ESSA Pharma
EPIX
$6.78M 6.8%
237,442
NEO icon
5
NeoGenomics
NEO
$1.27B
$6.68M 6.7%
147,921
LITS
6
Lite Strategy Inc
LITS
$69.2M
$6.64M 6.66%
116,566
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$3.99B
$5.55M 5.57%
294,620
+22,227
CYTK icon
8
Cytokinetics
CYTK
$7.25B
$4.84M 4.85%
244,673
FOLD icon
9
Amicus Therapeutics
FOLD
$2.69B
$4.82M 4.83%
+500,000
HRMY icon
10
Harmony Biosciences
HRMY
$1.66B
$4.23M 4.25%
150,000
INZY
11
DELISTED
Inozyme Pharma
INZY
$4.13M 4.14%
242,517
+73,044
YMAB
12
DELISTED
Y-mAbs Therapeutics
YMAB
$3.87M 3.88%
114,454
MIRM icon
13
Mirum Pharmaceuticals
MIRM
$3.5B
$3.56M 3.57%
205,866
ADCT icon
14
ADC Therapeutics
ADCT
$474M
$3.04M 3.05%
124,875
VSTM icon
15
Verastem
VSTM
$591M
$2.87M 2.88%
+58,799
MRUS icon
16
Merus
MRUS
$7.19B
$2.75M 2.76%
130,683
GERN icon
17
Geron
GERN
$791M
$2.7M 2.7%
1,912,673
TECX
18
Tectonic Therapeutic
TECX
$328M
$2.18M 2.18%
20,410
RVMD icon
19
Revolution Medicines
RVMD
$10.7B
$1.59M 1.59%
+50,000
BDTX icon
20
Black Diamond Therapeutics
BDTX
$219M
$1.35M 1.35%
110,447
GTHX
21
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.05M 1.05%
47,708
-70,000
TPTX
22
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$169K 0.17%
2,164
-70,000
APLS icon
23
Apellis Pharmaceuticals
APLS
$2.67B
– –
-80,727
TVRD
24
Tvardi Therapeutics
TVRD
$43.3M
– –
-5,000
TCDA
25
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-658,877
1
2